Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma

Programmed cell death-1 blockade in recurrent disseminated Ewing sarcoma

Abstract Background Ewing sarcoma (EWS) is a malignant tumour of bone and soft tissue, and although many patients are cured with conventional multimodal therapy, those with recurrent or metastatic disease have a poor prognosis. Genomic instability and programmed cell death ligand-1 (PD-L1) expressio...

Full description

Bibliographic Details
Main Authors: Georgia J. B. McCaughan, Michael J. Fulham, Annabelle Mahar, Judy Soper, Angela M. Hong, Paul D. Stalley, Martin H. N. Tattersall, Vivek A. Bhadri
Format: Article
Language:English
Published: BMC 2016-06-01
Series:Journal of Hematology & Oncology
Subjects:
Ewing sarcoma
Immunotherapy
Anti-programmed cell death-1 antibody
Case report
Online Access:http://link.springer.com/article/10.1186/s13045-016-0278-x

Internet

http://link.springer.com/article/10.1186/s13045-016-0278-x

Similar Items